Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upfront Plerixafor in Autologous Transplantation
NCT01339572Phase 2Completed
- Sponsor
- University of Florida
- Start
- Apr 2011
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of plerixafor in multiple myeloma (MM) and non-Hodgkin lymphoma (NHL) (2 arms), sponsored by University of Florida. Primary endpoint: Rate of successful collection with early introduction of plerixafor in patients predicted to be poor mobilizers. Started Apr 2011; status: completed.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01339572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01339572.